Walder Wyss advised Danish life science investor Novo Holdings through its acquisition of American pharma multinational Catalent. Globally active in the fields of life sciences and healthcare, Novo Holdings acts as the only asset manager
Walder Wyss advised Danish life science investor Novo Holdings through its acquisition of American pharma multinational Catalent. Globally active in the fields of life sciences and healthcare, Novo Holdings acts as the only asset manager